Related Experiment Video

Updated: Mar 21, 2026

In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells
09:40

In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells

Published on: November 2, 2017

7.8K

SUMOylation of Rb enhances its binding with CDK2 and phosphorylation at early G1 phase

Fengxi Meng1,2, Jiang Qian1,2, Han Yue1,2

  • 1a Department of Ophthalmology , Eye and ENT Hospital of Fudan University , Shanghai , China.

Cell Cycle (Georgetown, Tex.)
|May 11, 2016
PubMed

Insights

Small ubiquitin-like modifier (SUMO)ylation of Retinoblastoma protein (Rb) at early G1 phase promotes its phosphorylation by CDK2, enabling cell cycle progression. This SUMOylation is crucial for cell proliferation and E2F-1 release.

Area of Science:

  • Molecular Biology
  • Cell Cycle Regulation
  • Cancer Biology

Background:

  • Retinoblastoma protein (Rb) is a key tumor suppressor regulating cell cycle arrest.
  • Rb phosphorylation controls its interaction with E2F transcription factors, dictating cell cycle progression.
  • The precise mechanisms governing cell cycle-dependent Rb hyper-phosphorylation by cyclin-dependent kinases (CDKs) are not fully understood.

Purpose of the Study:

  • To elucidate the role of small ubiquitin-like modifier (SUMO)ylation in regulating Retinoblastoma protein (Rb) phosphorylation.
  • To investigate how SUMOylation influences the interaction between Rb and cyclin-dependent kinase 2 (CDK2).
  • To determine the impact of Rb SUMOylation on cell cycle progression and proliferation.

Main Methods:

  • Cell cycle analysis of Rb SUMOylation.
  • Biochemical assays to assess Rb phosphorylation and CDK2 binding.
  • Use of SUMO-deficient Rb mutants to study functional consequences.

Main Results:

  • Retinoblastoma protein (Rb) undergoes specific SUMOylation during early G1 phase.
  • SUMOylation enhances Rb phosphorylation by recruiting CDK2, facilitating E2F-1 release.
  • A SUMO-deficient Rb mutant exhibits reduced phosphorylation, weakened CDK2 binding, and impaired E2F-1 sequestration.
  • Rb SUMOylation is essential for normal cell proliferation.

Conclusions:

  • Rb SUMOylation represents a novel regulatory mechanism for cell cycle progression.
  • SUMOylation of Rb by CDK2 is critical for releasing E2F-1 and promoting cell proliferation.
  • This finding provides new insights into the complex regulation of tumor suppressor function.
Keywords:
CDK2RbSUMO-interaction motif (SIM)SUMOylationcell cyclephosphorylation

More Related Videos

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

19.4K
Analysis of Cell Cycle Position in Mammalian Cells12:19

Analysis of Cell Cycle Position in Mammalian Cells

Published on: January 21, 2012

61.5K

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.8K
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
7.0K
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
137.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

5.6K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.1K